Therapeutic Toll-like receptor agonists directly influence mouse and human T cell lymphoma cell viability and cytokine secretion

Click to increase image sizeClick to decrease image size

Acknowledgements

The authors would like to thank R. Levy and J. Aster for mouse cell lines. The authors would also like to thank members of the Utz Laboratory, O. M. Martinez, G. P. Nolan, and R. Levy for helpful discussion.

This work was supported by the US National Institutes of Health grant U19 AI082719, the Canadian Institutes of Health Research grant 20R-92141, The US National Institutes of Health grant U19 AI050864 and a gift from the Floren Family Trust. A.L. was supported by the National Science Foundation Graduate Research Fellowship. G.Y. was funded by the Stanford Medical Scientist Training Program (MSTP). K.A. was funded by the Stanford Institutes of Medical Research (SIMR) Program.

Potential conflict of interest: Disclosure forms provided by the authors are available with the full text of this article at www.informahealthcare.com/lal.